EUVIMEDOpdag EUVIMED
Crossref

Structural Elucidation of Fc- and Fab-Associated N -Glycans in Cetuximab Using Protein A-Assisted Domain-Resolved Glycan Profiling Using Mass Spectrometry

Divya Chauhan, Tarun Shivach, Anurag S Rathore iD

Journal of the American Society for Mass Spectrometry · 2026

DOI: 10.1021/jasms.6c00136 ↗

At a glance

Journal article in Journal of the American Society for Mass Spectrometry, 2026. Written by Divya Chauhan and 2 co-authors. Institution: Department of Chemical Engineering, Indian Institute of Technology, Hauz Khas, New Delhi, Delhi110016, India. Major MEDLINE topics: Polysaccharides, Immunoglobulin Fab Fragments, Immunoglobulin Fc Fragments, Cetuximab. 40 references.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Glycosylation of monoclonal antibodies is a key determinant of their efficacy, stability, and safety, requiring analytical methods capable of resolving site-specific heterogeneity with high sensitivity. In this work, we present a Protein A-assisted, domain-resolved glycan profiling approach for the mass spectrometry-based structural elucidation and quantification of N-glycans linked to Fc and Fab in cetuximab. Antibody domains were selectively extracted using Protein A affinity separation, allowing for independent enzymatic release of N-glycans from Fc and Fab sections, followed by high-resolution mass spectrometry for detailed glycan profiling and comparative characterization of Fc- and Fab-associated glycan populations. In comparison to conventional total glycan analysis, our technique decreases spectral complexity and allows for obvious distinction of domain-specific glycosylation patterns. Crucially, domain-specific released glycan profiling improves the detection and precise measurement of low-abundance glycoforms, such as sialylated, high-mannose, and afucosylated species that frequently remain hidden in conventional approaches. The proposed approach facilitates domain-specific characterization of glycan distributions across antibody regions by reducing analytical complexity and improving interpretation of Fc- and Fab-associated glycosylation patterns. Our results show that a reliable and repeatable platform for thorough, domain-level glycan characterization and quantification is available, supporting applications in quality control and biosimilar comparability studies, and in general during biopharmaceutical development.

Subjects

MeSH terms (MEDLINE)

PolysaccharidesImmunoglobulin Fab FragmentsImmunoglobulin Fc FragmentsCetuximabMass SpectrometryGlycosylationHumans

Author keywords

N-glycosylationFc/fab glycanscetuximabdomain-resolved glycan profilingmass spectrometryprotein A affinity

Substances

PolysaccharidesImmunoglobulin Fab FragmentsImmunoglobulin Fc FragmentsCetuximab

Authors and institutions

  • Department of Chemical Engineering, Indian Institute of Technology, Hauz Khas, New Delhi, Delhi110016, India.

ORCID profiles: Anurag S Rathore

Cite

APA

Chauhan, D., Shivach, T., & Rathore, A. S. (2026). Structural Elucidation of Fc- and Fab-Associated N -Glycans in Cetuximab Using Protein A-Assisted Domain-Resolved Glycan Profiling Using Mass Spectrometry. Journal of the American Society for Mass Spectrometry. https://doi.org/10.1021/jasms.6c00136

Vancouver

Chauhan D, Shivach T, Rathore AS. Structural Elucidation of Fc- and Fab-Associated N -Glycans in Cetuximab Using Protein A-Assisted Domain-Resolved Glycan Profiling Using Mass Spectrometry. Journal of the American Society for Mass Spectrometry. 2026. doi:10.1021/jasms.6c00136

BibTeX
@article{Chauhan2026,
  author = {Chauhan, Divya and Shivach, Tarun and Rathore, Anurag S},
  title = {Structural Elucidation of Fc- and Fab-Associated N -Glycans in Cetuximab Using Protein A-Assisted Domain-Resolved Glycan Profiling Using Mass Spectrometry},
  journal = {Journal of the American Society for Mass Spectrometry},
  year = {2026},
  doi = {10.1021/jasms.6c00136}
}
Start for free →